MedPath

Typhoid Vaccine Live

Generic Name
Typhoid Vaccine Live
Brand Names
Vivotif
Drug Type
Biotech
Unique Ingredient Identifier
0MZI008M96

Overview

Salmonella typhi Ty21a live antigen is a live attenuated vaccine for oral administration only. It contains the attenuated strain Salmonella typhi Ty21a. The vaccine prevents the development of typhoid fever, an acute, febrile enteric disease caused by Salmonella typhi by inducing a local immune response in the intestinal tract.

Background

Salmonella typhi Ty21a live antigen is a live attenuated vaccine for oral administration only. It contains the attenuated strain Salmonella typhi Ty21a. The vaccine prevents the development of typhoid fever, an acute, febrile enteric disease caused by Salmonella typhi by inducing a local immune response in the intestinal tract.

Indication

No indication information available.

Associated Conditions

  • Disease caused by Salmonella typhi

Clinical Trials

FDA Approved Products

Vivotif-B
Manufacturer:Rebel Distributors Corp
Route:ORAL
Strength:2 [CFU] in 1 1
Approved: 2011/03/18
NDC:21695-526

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath